Abstract:Background: Venous thromboembolism is a well-established preventable complication after colectomy. Specific guidance on venous thromboembolism prevention after colectomy for benign disease is limited. Objective: This meta-analysis aimed to quantify the venous thromboembolism risk after benign colorectal resection and determine its variability. Data sources: Following Preferred Reporting Items for Systematic Review and Meta-Analysis and Meta-analysis of Observational Studies in Epidemiology Guidelines (PROSPERO: CRD42021265438), Embase, MEDLINE, and 4 other registered medical literature databases were searched from the database inception to June 21, 2021. Study selection: Inclusion criteria: randomized controlled trials and large population-based database cohort studies reporting 30-day and 90-day venous thromboembolism rates after benign colorectal resection in patients aged ≥18 years. Exclusion criteria: patients undergoing colorectal cancer or completely endoscopic surgery. Main outcome measures: Thirty- and 90-day venous thromboembolism incidence rates per 1000 person-years after benign colorectal surgery. Results: Seventeen studies were eligible for meta-analysis reporting on 250,170 patients. Pooled 30-day and 90-day venous thromboembolism incidence rates after benign colorectal resection were 284 (95% CI, 224-360) and 84 (95% CI, 33-218) per 1000 person-years. Stratified by admission type, 30-day venous thromboembolism incidence rates per 1000 person-years were 532 (95% CI, 447-664) for emergency resections and 213 (95% CI, 100-453) for elective colorectal resections. Thirty-day venous thromboembolism incidence rates per 1000 person-years after colectomy were 485 (95% CI, 411-573) for patients with ulcerative colitis, 228 (95% CI, 181-288) for patients with Crohn's disease, and 208 (95% CI, 152-288) for patients with diverticulitis. Limitations: High degree of heterogeneity was observed within most meta-analyses attributable to large cohorts minimizing within-study variance. Conclusions: Venous thromboembolism rates remain high up to 90 days after colectomy and vary by indication for surgery. Emergency resections compared to elective benign resections have higher rates of postoperative venous thromboembolism. Further studies reporting venous thromboembolism rates by type of benign disease need to stratify rates by admission type to more accurately define venous thromboembolism risk after colectomy. Registration no: CRD42021265438.

Are IBD Patients Underscored when Determining Postoperative VTE Risk?

Analysis of Postoperative Venous Thromboembolism in Patients With Chronic Ulcerative Colitis: Is It the Disease or the Operation?

IDDF2018-ABS-0209 Venous Thromboembolism in Patients with Inflammatory Bowel Disease in China: Investigations into Incidence and Risk Factors

FP2.6 - Opportunities for Improvement in Venous Thromboprophylaxis (VTE) of High-Risk Patients Hospitalized for Inflammatory Bowel Disease (IBD) Related Bowel Resection

Is extended venous thromboprophylaxis required in patients undergoing ileal pouch procedure for ulcerative colitis?

Construction of Risk Assessment Model for Venous Thromboembolism after Colorectal Cancer Surgery: A Chinese Single-Center Study

Incidence and Risk Factors for Venous Thrombosis among Patients with Inflammatory Bowel Disease in China: a Multicenter Retrospective Study

Timing and Location of Venous Thromboembolisms After Surgery for Inflammatory Bowel Disease

Controversies in Venous Thromboembolism Risk Assessment in Inflammatory Bowel Disease: A Narrative Review

S1355 Compliance Rate of Venous Thromboembolism Prevention in Hospitalized Patients With Inflammatory Bowel Disease in a Community Hospital Setting

Risk assessment of venous thromboembolism in inflammatory bowel disease by inherited risk in a population-based incident cohort

Risk of Postoperative Venous Thromboembolism After Benign Colorectal Surgery: Systematic Review and Meta-analysis

Postoperative Venous Thromboembolism in Colon and Rectal Cancer: Do Tumor Location and Operation Matter?

Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery

S1186 Anticoagulation and Preprocedural Bleeding Risk in Patients with Inflammatory Bowel Disease

Effectiveness and Safety of Prophylactic Anticoagulation among Hospitalized Inflammatory Bowel Disease Patients

Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis

Seek and ye shall find: The utility of perioperative VTE screening in high‐risk oncologic patients undergoing abdominopelvic surgery

Venous Thromboembolism: A Review of Risk and Prevention in Colorectal Surgery Patients

Inflammatory Bowel Disease Therapy and Venous Thromboembolism

Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial